Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Grierson

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Sports Medicine (Auckland, N.Z.)|March 16, 2022
A Win-Win for Sport and Exercise Medicine and Primary Care: A Qualitative Case Study of the Added Competence Model in CanadaJane S Thornton, L Grierson, M Vanstone, et al.
Princess Takamatsu Symposia|January 1, 1987
X-linked lymphoproliferative syndrome provides clues to the pathogenesis of Epstein-Barr virus-induced lymphomagenesisD T Purtilo, N Yasuda, H L Grierson, et al.
Archives of Pathology & Laboratory Medicine|June 1, 1987
Fatal infectious mononucleosis and virus-associated hemophagocytic syndromeE C Mroczek, D D Weisenburger, H L Grierson, et al.
Clinical Microbiology Reviews|July 1, 1988
Epstein-Barr virus and human diseases: recent advances in diagnosisM Okano, G M Thiele, J R Davis, et al.
American Journal of Medical Genetics|July 1, 1989
Chromosome deletion of Xq25 in an individual with X-linked lymphoproliferative diseaseH E Wyandt, H L Grierson, W G Sanger, et al.
Gastroenterology|December 1, 1987
Hepatitis in fatal infectious mononucleosisR S Markin, J Linder, K Zuerlein, et al.
Clinical Immunology and Immunopathology|March 1, 1990
Immunovirological studies of fatal infectious mononucleosis in a patient with X-linked lymphoproliferative syndrome treated with intravenous immunoglobulin and interferon-alphaM Okano, S J Pirruccello, H L Grierson, et al.
Cancer Genetics and Cytogenetics|July 15, 1990
Partial Xq25 deletion in a family with the X-linked lymphoproliferative disease (XLP)W G Sanger, H L Grierson, J Skare, et al.
Clinical Immunology and Immunopathology|May 1, 1987
Thymic lesions in fatal infectious mononucleosisE C Mroczek, T A Seemayer, H L Grierson, et al.
European Journal of Immunology|November 28, 2000
Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicityH Nakajima, M Cella, A Bouchon, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Sports Medicine (Auckland, N.Z.)|March 16, 2022
A Win-Win for Sport and Exercise Medicine and Primary Care: A Qualitative Case Study of the Added Competence Model in CanadaJane S Thornton, L Grierson, M Vanstone, et al.
Princess Takamatsu Symposia|January 1, 1987
X-linked lymphoproliferative syndrome provides clues to the pathogenesis of Epstein-Barr virus-induced lymphomagenesisD T Purtilo, N Yasuda, H L Grierson, et al.
Archives of Pathology & Laboratory Medicine|June 1, 1987
Fatal infectious mononucleosis and virus-associated hemophagocytic syndromeE C Mroczek, D D Weisenburger, H L Grierson, et al.
Clinical Microbiology Reviews|July 1, 1988
Epstein-Barr virus and human diseases: recent advances in diagnosisM Okano, G M Thiele, J R Davis, et al.
American Journal of Medical Genetics|July 1, 1989
Chromosome deletion of Xq25 in an individual with X-linked lymphoproliferative diseaseH E Wyandt, H L Grierson, W G Sanger, et al.
Gastroenterology|December 1, 1987
Hepatitis in fatal infectious mononucleosisR S Markin, J Linder, K Zuerlein, et al.
Clinical Immunology and Immunopathology|March 1, 1990
Immunovirological studies of fatal infectious mononucleosis in a patient with X-linked lymphoproliferative syndrome treated with intravenous immunoglobulin and interferon-alphaM Okano, S J Pirruccello, H L Grierson, et al.
Cancer Genetics and Cytogenetics|July 15, 1990
Partial Xq25 deletion in a family with the X-linked lymphoproliferative disease (XLP)W G Sanger, H L Grierson, J Skare, et al.
Clinical Immunology and Immunopathology|May 1, 1987
Thymic lesions in fatal infectious mononucleosisE C Mroczek, T A Seemayer, H L Grierson, et al.
European Journal of Immunology|November 28, 2000
Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicityH Nakajima, M Cella, A Bouchon, et al.
Pageof 3